rfhg_123404.1

Basic information about the TSS

---

TSS ID: rfhg_123404.1 TSS ID(Version3): hg_104097.1 hg_104099.1 hg_104098.1 Species: human Chr: chr10		Start: 17644138 End: 17644281 Strand: +
Source datasets	FANTOM5|DRA000914|ENCODE|PRJNA548673|PRJNA4843412|DRA013844 |PRJNA401781|PRJNA597322|PRJNA615891|PRJDB5282
Protocol	CAGE|ReCappable-seq|NETCAGE|oligo_capping|STRIPE-seq |SLIC_CAGE|TIF-seq2|RAMPAGE|C1CAGE
TSS cluster detected*	14

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2319878,EH38E1452041)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000377524.8:0 ENST00000445846.1:0 ENST00000377500.1:0 BC030586:0 AK314405:0 AK303083:0 GeneID: 8027 HGNC/MGI_ID: HGNC:11357 UniProt_ID: A6NMU3 B2RAY1 B4DZT2 C9J1E5 Q92783 Nearer transcript ids and distances: U43899:17 CU688920:59 KJ901858:59 AB590764:59 view more...

Gene_name: signal transducing adaptor molecule Gene_symbol: STAM Gene_synonyms: STAM1 Gene_source: HGNC:11357

TATA-Box annotation

---

Distance to TSS:	58
Nearest PromoterID:	NM_001324285
Entrez ID:	8027
Nearest Unigene:	Hs.335391
Nearest Refseq:	NM_003473
Nearest Ensembl:	ENSG00000136738
Gene Name:	signal transducing adaptor molecule
Gene Alias:	STAM-1|STAM1
Gene Type:	protein-coding
CpG%:	0.076923
GC%:	0.631944
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@STAM p2@STAM p3@STAM p4@STAM p5@STAM
Sample		p1@STAM	p2@STAM	p3@STAM	p4@STAM	p5@STAM
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.42	11.49	7.60	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	14.57	13.15	4.25	0.40	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.73	10.42	6.75	0.77	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	11.02	13.72	4.99	1.25	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	13.05	11.70	4.72	1.35	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	15.50	11.43	7.75	0.78	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	19.83	6.10	6.97	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	17.44	7.51	3.88	1.21	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	14.96	8.76	6.20	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.91	7.54	4.64	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	18.19	5.66	4.45	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	12.20	5.69	7.32	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	17.89	10.32	3.39	0.48	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.04	11.28	3.91	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	16.69	8.56	3.07	0.66	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.32	12.07	4.28	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	16.82	10.70	3.49	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.39	11.39	4.22	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	9.06	12.26	3.73	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.73	9.33	4.36	0.30	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	14.84	9.89	3.47	1.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.60	12.43	4.83	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.25	11.76	4.01	0.65	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.26	8.74	3.40	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	16.00	9.55	4.39	1.03	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	13.29	6.96	3.80	0.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	9.89	2.20	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	14.62	9.90	5.42	1.65	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	9.05	5.81	1.62	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.31	9.41	3.08	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.51	6.49	2.93	1.47	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	11.53	7.82	3.32	1.56	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.40	7.81	2.95	1.48	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.24	12.37	2.64	2.14	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	11.59	8.60	2.80	1.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11.69	7.09	3.26	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	9.81	9.20	2.86	2.04	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	10.28	8.66	1.81	1.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.96	10.26	1.08	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.16	7.92	1.68	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	11.06	6.12	3.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.98	9.52	3.66	1.32	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	11.60	5.91	3.59	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.29	6.99	1.92	0.87	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.65	7.63	1.81	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	11.17	7.44	2.09	1.40	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	14.15	4.32	2.64	2.40	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.22	8.05	2.68	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.40	5.51	3.59	1.20	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	11.73	5.26	3.44	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	12.30	6.97	1.84	1.02	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	16.68	8.23	4.00	0.89	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	111.94	55.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.10	12.07	1.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	12.26	6.63	1.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	39.43	32.72	5.87	4.19	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.78	9.64	5.05	0.92	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	20.74	6.81	2.92	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	13.49	6.74	4.18	1.61	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	16.35	9.74	3.14	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	15.51	3.53	4.94	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	13.46	8.97	6.73	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	23.09	6.37	6.37	3.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	14.95	8.15	2.04	1.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	15.60	4.87	1.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	14.55	4.61	1.77	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	86.87	55.28	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.60	3.41	1.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	16.86	5.45	3.47	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.23	4.69	2.35	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.88	6.62	1.99	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	15.47	4.02	2.17	0.62	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	16.51	4.28	2.75	0.31	0.92
Adipocyte - breast, donor1	11376-118A8	19.96	12.51	4.12	0.00	0.63
Adipocyte - breast, donor2	11327-117E4	14.28	8.98	3.21	0.16	0.48
Adipocyte - omental, donor1	11473-119C6	20.23	14.00	4.45	0.00	0.38
Adipocyte - omental, donor2	11474-119C7	10.46	10.46	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	10.05	7.37	2.68	0.00	1.34
Adipocyte - perirenal, donor1	11476-119C9	15.31	5.74	1.28	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	13.10	4.06	1.81	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	8.34	2.43	0.70	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	17.60	10.76	5.28	0.59	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	10.04	9.52	1.80	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	13.10	6.69	3.62	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	11.17	8.82	2.35	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	20.59	9.65	4.83	0.00	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	14.52	7.42	2.58	0.97	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	17.06	12.80	2.13	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	13.35	3.90	1.67	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	15.80	4.57	1.66	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	11.55	4.52	2.76	0.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	11.78	8.51	1.64	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	13.09	3.96	3.35	0.00	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	13.70	2.21	2.87	1.10	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	7.53	0.72	0.72	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	19.07	10.07	4.32	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	5.02	5.02	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	11.92	5.75	0.62	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	10.30	9.27	2.52	1.72	0.11
Anulus Pulposus Cell, donor2	11463-119B5	9.31	5.14	2.45	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	4.49	1.35	1.35	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.95	5.21	1.74	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	8.56	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	9.57	5.08	2.69	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5.06	6.32	0.00	1.26	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.26	3.96	1.32	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.47	3.90	1.95	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.68	4.85	2.43	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	3.56	5.94	1.19	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	8.66	5.65	1.51	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	8.71	7.98	3.63	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	5.02	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.86	5.44	3.95	0.49	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	2.73	4.09	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.39	5.28	1.36	0.90	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	5.89	6.97	3.75	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.12	4.53	1.32	0.76	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.88	7.75	1.34	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	8.78	4.88	1.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	9.95	4.98	2.49	0.33	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	4.80	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	14.16	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.06	4.97	0.86	0.17	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.83	7.77	1.46	0.00	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.21	3.79	2.28	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	2.42	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.70	4.56	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.34	5.77	1.50	0.21	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	7.23	2.32	2.06	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	5.63	4.22	2.82	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.97	4.82	1.29	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	3.57	2.14	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.77	4.09	1.17	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.83	5.72	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	1.19	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.65	6.10	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.64	4.84	1.53	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	4.45	4.45	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.06	4.75	0.86	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.53	5.50	1.48	0.64	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.64	3.77	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	7.56	4.72	4.72	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	10.51	5.09	1.36	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	9.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	6.34	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.65	5.36	2.14	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5.41	7.22	1.80	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	7.29	7.29	0.73	0.73	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.28	7.36	2.53	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	10.17	5.08	2.03	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.73	7.02	3.10	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.43	4.90	0.92	0.92	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.21	10.04	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.09	5.32	2.22	0.00	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	7.63	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.42	2.77	1.66	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.27	4.77	1.32	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.09	3.63	1.45	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	13.26	9.33	3.07	1.97	0.12
Astrocyte - cerebellum, donor2	11580-120F5	8.73	3.25	1.20	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	4.61	3.99	0.84	0.84	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	17.78	11.50	8.71	5.58	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	16.82	8.09	6.79	1.46	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	18.65	6.26	5.22	1.04	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	15.14	13.76	7.23	1.72	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	13.03	17.79	8.02	2.38	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	10.81	13.20	5.46	1.14	0.11
Basophils, donor1	12241-129G9	18.05	44.20	7.06	0.78	0.00
Basophils, donor2	12242-129H1	14.43	45.46	3.61	0.36	0.00
Basophils, donor3	12243-129H2	11.76	21.31	2.94	0.44	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	16.39	1.51	1.29	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	6.86	0.91	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.83	5.02	1.88	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	15.60	3.95	1.46	0.42	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	29.25	2.30	1.38	0.23	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	17.63	2.88	2.88	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	5.15	11.54	4.95	5.46	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	13.51	10.48	6.06	5.36	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	7.99	19.83	3.84	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	62.05	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	7.33	8.45	2.25	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	9.84	20.79	2.60	0.93	0.93
CD14+ Monocytes, donor3	11381-118B4	12.51	24.59	2.41	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	42.17	24.91	4.25	0.00	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	56.10	24.26	6.44	0.00	3.03
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	52.60	30.24	7.89	0.00	2.96
CD14+ monocytes - mock treated, donor1	11863-125A9	10.99	16.19	1.59	0.43	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	9.96	8.15	2.72	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	13.98	9.71	1.90	0.95	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	12.05	12.55	1.84	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	8.56	12.14	0.83	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	17.60	15.87	1.49	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.09	5.09	0.59	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.99	5.70	0.71	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	9.36	10.66	1.74	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	10.07	10.30	1.64	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	10.56	22.18	1.58	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	22.19	1.11	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	11.60	16.51	1.34	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.78	12.77	1.60	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.03	20.61	1.04	0.21	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.49	9.61	2.06	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.33	10.18	2.26	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	7.42	14.84	1.75	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.88	6.46	1.61	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	9.07	9.07	1.05	0.35	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	14.31	11.36	0.84	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.70	4.96	0.73	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.69	3.87	0.70	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.58	10.09	1.32	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	8.54	7.15	1.05	0.87	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.95	7.81	0.74	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	14.44	15.30	3.23	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.14	6.55	1.23	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.40	7.65	1.16	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.35	10.44	1.86	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	13.08	6.97	1.31	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	15.01	4.62	1.15	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	13.43	3.47	1.08	0.22	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	24.29	5.61	2.96	0.00	1.25
CD14+CD16- Monocytes, donor2	11799-124C8	15.72	5.94	2.45	0.35	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	28.32	6.02	2.01	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	12.50	3.83	1.53	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	16.25	4.39	3.29	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	18.32	2.74	2.53	0.21	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	6.10	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.27	13.56	4.75	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	16.57	11.39	4.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	15.99	19.72	9.06	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	16.62	9.11	6.97	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	14.74	13.34	4.91	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	18.04	7.06	7.06	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	21.09	14.50	2.64	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	18.08	31.23	7.40	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	16.68	42.07	8.71	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	16.15	40.39	9.09	1.51	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	245.26	167.68	55.76	19.39	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	156.20	109.86	39.95	15.18	1.60
CD34+ Progenitors, donor1	11545-120B6	11.04	48.19	7.03	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	11.80	55.62	4.49	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	13.15	25.55	7.14	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	17.81	30.89	9.92	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	32.14	170.32	14.64	0.71	0.71
CD4+ T Cells, donor2	11306-117C1	13.47	127.98	10.41	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	27.75	141.82	10.67	2.74	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	34.46	81.17	14.55	5.36	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	38.41	85.12	19.76	4.49	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	35.36	64.97	18.97	3.74	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	52.62	214.29	24.18	1.42	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	56.19	196.65	26.69	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	148.33	19.78	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	24.42	65.03	12.28	3.32	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	24.40	53.89	9.49	1.19	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	24.18	49.49	9.67	2.26	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	53.35	376.12	32.28	8.52	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	57.65	422.76	33.89	8.04	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	70.84	544.26	51.92	5.28	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	34.15	40.48	14.76	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	26.39	25.97	9.56	0.83	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	27.73	21.05	6.35	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	20.94	25.02	10.06	0.00	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	25.19	26.80	10.72	1.07	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	12.55	14.35	5.38	1.79	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	21.14	28.56	9.46	1.67	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	15.60	21.45	6.93	1.08	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	10.72	24.38	7.99	0.00	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	18.20	49.55	7.08	1.01	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	26.43	62.39	10.83	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	31.38	62.76	17.43	0.44	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	27.22	35.14	14.85	0.49	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	22.16	19.39	11.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	13.96	20.94	11.17	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	31.02	41.54	10.52	0.28	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	36.56	43.92	10.06	0.49	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	26.18	29.26	10.78	3.08	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	35.10	36.89	10.74	1.43	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	20.77	26.31	4.15	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	9.17	70.72	5.89	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	7.51	52.56	6.01	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	11.36	63.12	7.57	0.25	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	6.19	2.52	1.38	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.27	1.44	1.20	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	7.93	2.74	1.37	1.09	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	8.41	3.60	3.00	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	5.52	3.36	3.12	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.91	3.18	1.36	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	4.78	5.00	1.96	0.65	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.79	2.90	1.32	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.69	3.99	2.81	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	4.53	3.32	2.11	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	1.74	5.81	1.45	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	5.86	1.87	1.33	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.06	7.44	1.31	1.31	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	3.64	6.38	2.28	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.98	4.48	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	9.36	1.80	2.16	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.32	4.60	1.73	1.15	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.19	3.77	1.65	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	6.34	2.22	2.22	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.61	4.61	2.46	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	6.73	6.09	1.28	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	6.88	1.53	1.15	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	4.34	1.18	1.18	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	3.78	1.51	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	7.23	7.23	0.00	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	5.60	3.50	1.40	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	13.02	7.01	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	7.31	16.45	1.83	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	5.43	5.93	3.46	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	12.31	6.21	2.42	0.53	0.11
Chondrocyte - de diff, donor1	11261-116G1	28.08	4.51	3.12	1.39	0.69
Chondrocyte - de diff, donor2	11338-117F6	9.60	11.73	2.49	0.00	1.42
Chondrocyte - de diff, donor3	11410-118E6	12.86	6.94	3.30	0.91	0.68
Chondrocyte - re diff, donor2	11339-117F7	45.66	24.17	8.95	2.69	0.90
Chondrocyte - re diff, donor3	11411-118E7	12.94	6.87	0.40	0.00	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	13.89	24.44	8.49	2.41	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	11.97	14.54	4.06	0.64	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	11.15	16.11	5.49	0.71	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	36.59	9.08	6.24	10.09	1.83
Corneal Epithelial Cells, donor1	11526-119I5	9.66	1.10	0.22	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	10.24	2.28	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.71	2.30	0.26	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	21.30	5.45	1.82	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	17.66	4.42	1.26	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.82	4.86	1.30	0.00	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	4.78	28.01	5.81	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	5.22	25.46	7.18	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	7.74	25.65	7.74	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	17.84	3.17	1.17	0.67	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	15.26	4.11	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.57	3.11	1.70	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	13.37	1.57	2.75	0.39	0.79
Endothelial Cells - Artery, donor1	11264-116G4	6.11	3.49	1.75	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	12.71	3.29	2.59	0.24	0.47
Endothelial Cells - Artery, donor3	11413-118E9	14.20	4.73	3.33	0.53	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	15.74	2.88	1.77	0.89	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	19.47	6.09	3.65	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	24.53	10.43	5.07	0.85	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	10.10	3.86	2.08	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	12.50	2.08	1.04	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	7.09	1.84	1.13	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	24.01	6.80	3.60	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	5.24	2.62	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	24.35	9.94	7.21	0.87	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	13.47	4.78	3.69	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	16.12	4.64	2.44	0.00	0.49
Endothelial Cells - Vein, donor1	11267-116G7	10.24	2.28	2.28	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	10.48	4.19	2.10	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	10.68	2.04	1.88	0.63	0.16
Eosinophils, donor1	12244-129H3	45.74	15.25	15.25	15.25	0.00
Eosinophils, donor2	12245-129H4	31.35	26.40	4.95	3.30	1.65
Eosinophils, donor3	12246-129H5	49.94	24.97	3.57	0.00	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	10.02	1.71	0.49	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	25.45	11.49	3.28	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.32	5.04	1.31	0.11	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.83	4.66	2.49	0.33	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	19.77	8.25	4.12	0.73	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	58.14	20.61	9.14	0.68	2.32
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.97	7.70	3.06	0.21	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	34.52	12.12	4.22	0.53	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	17.27	4.65	1.99	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	6.35	6.80	1.36	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	12.89	3.79	0.76	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	7.73	3.94	2.21	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	27.28	19.40	8.49	1.21	0.91
Fibroblast - Cardiac, donor5	11456-119A7	20.81	9.77	2.16	0.38	0.25
Fibroblast - Cardiac, donor6	11460-119B2	15.77	8.64	3.79	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.05	13.13	5.49	0.40	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	3.02	11.22	2.16	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	16.11	14.65	5.86	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	19.37	4.38	2.54	0.69	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	14.08	16.96	6.95	2.88	0.34
Fibroblast - Dermal, donor1	11269-116G9	13.38	2.11	0.94	0.70	0.23
Fibroblast - Dermal, donor2	11346-117G5	14.62	4.72	1.42	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	10.88	3.02	1.09	0.24	0.48
Fibroblast - Dermal, donor4	11450-119A1	18.99	4.07	2.03	0.34	1.13
Fibroblast - Dermal, donor5	11454-119A5	35.59	4.36	2.79	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	33.30	5.36	1.95	0.65	1.30
Fibroblast - Gingival, donor1	11237-116D4	22.28	8.54	3.33	2.08	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	19.65	10.74	3.14	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	21.09	3.16	3.03	1.05	0.66
Fibroblast - Gingival, donor3	11394-118C8	22.33	8.41	2.90	0.48	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	13.51	4.16	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.39	5.29	2.29	0.00	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	23.07	7.17	3.12	1.40	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	20.42	7.17	3.65	0.95	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	12.70	4.59	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	19.60	8.77	2.63	0.88	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	19.77	12.14	4.09	0.41	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	22.05	8.12	2.41	0.22	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.41	4.70	1.91	0.73	0.44
Fibroblast - Lung, donor1	11270-116H1	10.87	8.16	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	23.87	2.98	2.98	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	14.77	3.38	2.11	1.06	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	19.99	1.67	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	2.80	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.60	1.96	0.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	20.30	9.74	4.47	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	7.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	28.32	4.07	3.30	3.10	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	28.21	3.79	3.03	0.76	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	38.25	11.32	8.57	2.45	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	12.59	6.11	4.20	0.38	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.28	8.10	4.32	0.00	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.63	6.15	1.86	0.23	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.92	4.09	3.09	0.77	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	21.94	8.53	4.67	3.25	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.02	1.34	1.34	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	12.26	2.37	1.58	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	46.83	24.81	5.75	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	21.14	8.88	3.91	1.42	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	23.06	13.80	4.53	1.77	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	42.42	19.86	5.11	0.60	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	26.56	16.73	4.10	1.73	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	38.47	19.23	7.34	0.76	1.77
Fibroblast - skin normal, donor1	11553-120C5	18.21	10.17	4.43	1.15	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	51.53	16.44	9.42	0.80	1.80
Fibroblast - skin normal, donor2	11561-120D4	26.62	12.76	3.82	1.81	1.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	61.35	28.11	8.46	0.91	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	20.13	11.93	4.23	1.33	0.75
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	17.78	18.98	6.50	1.88	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	33.17	23.32	3.94	0.00	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	31.96	19.49	7.14	1.70	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	23.45	8.10	3.54	1.18	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.11	9.57	1.73	1.41	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	155.12	88.64	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	38.35	13.94	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	27.74	6.24	2.60	0.17	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	29.67	10.41	3.12	0.00	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	28.87	5.62	2.56	0.00	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	13.78	18.37	2.30	4.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	14.04	17.87	5.10	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	21.97	13.98	7.42	2.28	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	17.92	19.58	9.65	3.58	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	13.47	12.10	6.39	0.91	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	19.42	10.50	7.33	1.78	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	13.22	18.24	7.93	1.32	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	13.70	12.72	8.48	1.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	20.78	11.06	7.52	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	9.89	11.73	8.06	1.41	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	12.44	11.33	5.30	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.94	15.85	6.45	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	14.12	15.86	5.95	0.87	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	14.53	14.12	7.48	0.55	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	11.79	12.60	5.08	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	11.41	10.27	5.02	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	16.57	14.70	8.10	1.00	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	18.58	10.93	5.68	0.87	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	10.64	14.18	5.61	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	11.13	14.78	6.04	0.48	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	13.18	10.50	5.59	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	9.88	12.30	6.86	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	9.16	14.42	8.31	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	18.89	18.36	11.00	0.80	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.27	28.72	16.23	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.79	29.37	15.37	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	8.41	17.15	7.41	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.06	16.89	11.15	0.33	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.68	16.74	13.88	0.41	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	6.40	13.41	5.16	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	8.42	11.18	8.53	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	8.84	10.84	5.50	0.50	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	8.82	13.89	6.83	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	9.35	14.27	8.36	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	7.78	10.21	6.65	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	7.70	20.85	7.06	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	9.66	11.09	4.74	0.28	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	8.54	13.13	6.17	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	5.47	13.99	6.39	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	7.63	13.17	7.42	0.10	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	9.00	11.20	6.37	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	8.70	11.50	6.73	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.96	12.13	6.11	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	5.62	19.79	4.55	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	11.93	11.32	7.80	0.15	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	7.12	12.44	6.09	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	11.66	14.37	3.52	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	8.48	16.22	6.27	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	8.55	11.18	3.95	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	24.79	20.83	14.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	8.57	9.89	6.33	0.13	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	7.67	9.08	3.23	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	43.46	95.31	32.79	0.51	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	21.70	25.08	14.93	2.79	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	13.56	14.64	7.86	0.77	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	11.87	20.25	11.25	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	7.51	14.39	6.57	0.94	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.61	12.71	5.65	2.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	15.22	26.29	9.69	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	12.37	7.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	12.38	18.57	8.90	1.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	14.44	6.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	15.65	20.87	8.69	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	8.79	15.95	7.16	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	11.12	22.24	6.59	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	16.66	13.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	9.51	16.22	8.39	2.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	11.77	17.98	6.21	2.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.90	14.26	8.39	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	16.86	18.77	10.81	2.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	10.87	16.98	9.85	2.04	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	8.35	10.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	16.61	20.04	12.03	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	11.54	12.14	10.06	1.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	6.78	6.78	6.78	6.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	12.01	19.88	7.87	1.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	10.82	19.56	10.82	1.38	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.45	15.76	5.77	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.06	13.04	8.80	2.61	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	11.37	6.69	4.68	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	15.03	10.79	9.25	3.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	17.46	32.86	10.27	1.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	19.88	7.45	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	15.57	19.35	8.97	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	15.69	15.09	12.07	2.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	16.79	14.75	11.70	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	13.56	19.14	9.17	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.31	12.83	11.35	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	14.17	21.25	5.90	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	20.42	19.25	8.17	2.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	16.68	18.87	7.46	2.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	12.72	16.95	10.17	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	9.55	17.91	6.57	4.18	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	11.65	14.56	4.37	2.91	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	6.85	5.71	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.41	5.41	2.08	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	5.62	3.37	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.78	6.98	1.59	0.32	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.61	3.76	1.67	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	21.24	7.66	3.95	0.46	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	25.66	6.75	3.38	0.51	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	26.85	4.55	3.19	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	22.85	5.68	3.72	0.66	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	20.63	9.24	4.73	0.00	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	22.60	7.10	1.72	0.22	1.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	16.31	7.97	3.36	0.87	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	16.30	6.00	3.77	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	19.54	4.81	0.32	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	2.80	1.12	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.63	0.87	1.73	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	5.29	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	13.40	7.41	2.12	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	2.91	0.73	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.49	5.59	1.40	1.22	0.17
Hepatocyte, donor1	11523-119I2	23.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	16.16	3.23	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	14.72	3.68	1.23	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	2.61	54.17	7.18	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	57.33	24.47	10.66	2.45	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	11.39	11.53	4.80	0.82	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	6.37	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	1.38	4.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	5.13	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	34.11	3.25	9.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	1.67	1.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	3.63	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	9.26	3.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	17.74	4.43	5.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	5.24	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	12.60	8.19	6.30	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	13.92	12.37	1.55	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	16.80	7.75	3.88	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	6.44	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.93	8.15	6.52	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	7.98	5.46	2.10	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.88	5.63	3.21	0.80	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	13.85	5.54	2.77	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.02	6.61	1.42	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	11.79	6.35	0.91	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	29.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	21.52	3.23	3.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	24.14	6.35	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	32.86	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	18.49	4.46	4.46	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	9.11	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	11.43	7.14	6.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	13.27	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	10.49	5.56	4.01	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	28.10	10.54	7.02	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	6.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	20.86	4.17	2.09	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	2.21	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	9.73	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	18.31	2.62	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	0.00	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	20.27	0.00	3.20	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	19.40	4.16	1.39	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	37.04	0.00	11.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	16.57	2.76	7.36	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	3.03	3.03	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	6.21	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	4.23	5.29	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	26.03	9.22	2.94	0.00	0.33
Keratinocyte - epidermal, donor2	11349-117G8	11.71	1.76	0.59	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	24.04	6.44	1.80	0.09	0.47
Keratinocyte - oral, donor1	11251-116E9	36.67	10.10	4.54	0.23	1.02
Keratocytes, donor1	11527-119I6	34.73	1.38	2.41	1.38	0.69
Keratocytes, donor2	11607-120I5	7.03	2.34	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	21.54	3.75	2.96	0.79	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	11.87	18.34	4.31	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	14.07	13.84	8.19	2.54	0.23
Lens Epithelial Cells, donor3	11690-122I7	13.93	12.82	4.64	0.20	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.45	3.08	2.37	0.24	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.98	0.84	0.56	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.65	2.52	2.99	0.63	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	3.23	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	6.30	1.89	0.95	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.25	2.48	1.19	0.11	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	8.62	1.64	3.28	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.05	1.01	0.76	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.74	2.39	1.83	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	6.72	3.56	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.72	2.52	1.55	0.58	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.18	2.04	1.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.06	5.92	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.78	2.39	2.15	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.87	1.51	1.10	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.63	3.08	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.43	3.43	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5.31	2.01	1.10	0.73	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.84	2.63	0.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.69	0.29	1.17	0.88	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.98	1.49	1.49	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	12.12	2.91	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.43	3.50	1.08	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.42	2.27	0.61	0.61	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.33	4.15	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.31	4.19	0.63	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.01	2.26	1.65	0.60	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	0.69	2.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.71	2.63	1.32	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.94	1.38	1.17	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.63	4.36	1.45	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	10.25	2.32	1.32	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.19	1.12	0.87	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.81	4.07	2.96	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.91	3.71	1.73	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.74	1.79	1.24	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	10.29	3.54	1.29	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	16.43	4.26	2.13	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.34	2.94	1.26	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	11.73	2.13	0.36	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.73	0.48	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.78	1.71	0.78	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.46	2.86	0.72	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.15	2.94	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.94	1.41	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.34	3.59	2.97	0.87	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.68	1.54	1.54	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.86	2.69	0.90	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	2.27	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	21.48	5.37	3.07	3.84	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	13.36	5.20	4.45	3.71	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	19.04	1.27	2.54	3.39	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	23.91	1.41	0.70	3.52	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	9.34	4.67	1.87	3.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.22	5.67	0.52	2.06	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	13.08	4.76	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.06	1.36	1.13	3.17	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	14.83	3.20	2.04	2.33	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	18.91	2.70	1.35	5.40	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	22.76	4.06	3.25	5.55	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	15.41	4.11	1.54	4.62	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	17.29	2.82	2.12	1.41	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	12.66	3.33	1.33	3.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.92	6.62	1.53	2.55	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.94	3.47	3.47	4.00	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	18.33	3.59	0.57	1.32	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.18	4.91	3.07	4.29	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	20.39	2.45	0.82	6.52	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	19.37	2.50	2.71	1.25	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.62	4.48	3.08	4.48	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	2.06	3.09	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	16.26	4.35	4.06	4.35	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	20.93	3.89	0.30	1.79	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.28	2.21	2.21	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.92	8.84	1.77	5.66	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	21.76	4.79	2.58	2.58	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	19.57	2.30	1.15	3.45	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	21.11	2.69	2.69	3.84	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.81	5.66	2.26	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.95	4.10	0.82	5.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	14.01	2.26	1.36	2.71	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	13.64	2.87	3.59	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	19.42	4.48	0.75	2.99	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	21.55	3.34	3.72	3.72	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	24.12	2.15	2.15	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	20.55	0.86	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	19.32	2.33	1.33	4.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	22.32	2.41	0.60	3.02	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.80	2.13	4.27	4.98	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	12.03	3.78	2.75	1.72	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	23.08	3.22	2.15	4.83	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	19.53	3.37	3.37	4.04	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	23.71	4.82	1.11	5.93	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	2.33	1.16	5.81	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	11.64	4.23	1.06	3.17	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	18.81	2.40	1.20	6.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	22.53	2.91	1.45	3.63	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	23.00	6.13	0.00	2.30	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	23.68	6.41	2.47	5.43	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	27.29	2.82	3.76	5.65	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	22.12	2.01	2.01	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	18.93	3.15	3.15	4.51	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	1.72	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	17.37	3.56	3.12	6.68	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	17.99	3.91	3.13	4.30	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.15	6.60	2.64	4.62	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	22.31	3.63	2.59	4.67	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	23.19	3.94	2.63	5.69	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	13.42	5.03	2.80	3.35	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	20.32	3.09	3.09	3.53	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	19.29	3.47	1.16	5.01	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	19.24	2.03	1.01	5.06	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	17.30	3.84	1.92	5.29	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	16.30	5.57	2.39	3.18	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	24.91	3.65	1.82	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	18.68	3.46	0.00	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	21.28	4.18	2.66	3.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	21.69	3.10	3.10	5.68	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	16.33	2.42	0.60	1.81	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	16.80	4.12	1.27	4.44	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	24.52	2.67	2.67	3.20	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	23.56	0.57	0.57	4.60	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.60	3.60	1.54	4.11	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.17	5.66	2.83	2.12	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.00	1.70	1.13	0.00	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	22.05	6.66	2.08	3.74	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	27.41	5.48	0.00	5.48	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.28	4.59	2.51	5.85	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	20.44	2.32	1.86	2.79	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.73	0.67	1.34	2.01	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	21.39	1.07	1.60	4.28	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	20.61	2.83	1.21	3.64	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	15.60	1.84	1.84	1.84	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	0.89	0.89	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	23.36	2.85	2.85	2.85	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	23.01	2.30	2.30	3.07	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	33.92	4.38	1.64	3.28	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	17.82	3.12	1.34	3.56	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	29.63	2.34	1.04	4.16	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	36.47	3.32	0.66	3.98	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	4.16	2.08	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	28.95	9.57	3.19	0.00	1.60
Macrophage - monocyte derived, donor2	11313-117C8	19.27	4.59	1.84	0.00	1.47
Macrophage - monocyte derived, donor3	11389-118C3	20.58	5.90	2.75	0.00	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	15.40	8.50	1.06	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	39.45	16.48	4.75	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	31.27	19.18	5.28	0.42	0.42
Mammary Epithelial Cell, donor1	11273-116H4	43.54	11.86	5.28	0.80	1.00
Mammary Epithelial Cell, donor2	11350-117G9	25.77	6.66	3.47	1.45	0.29
Mammary Epithelial Cell, donor3	11422-118F9	15.96	2.99	1.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	176.94	336.93	52.20	4.07	1.36
Mast cell, donor1	11563-120D6	63.26	91.38	21.20	1.19	1.30
Mast cell, donor2	11565-120D8	75.19	87.07	20.80	0.30	1.49
Mast cell, donor3	11566-120D9	56.96	43.67	10.36	0.23	3.15
Mast cell, donor4	11567-120E1	79.25	82.97	18.79	0.18	3.01
Mast cell, expanded and stimulated, donor5	11940-126A5	71.30	63.21	19.52	0.89	1.11
Mast cell, expanded and stimulated, donor8	11942-126A7	30.94	50.20	8.76	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	56.67	41.99	12.62	1.38	0.92
Mast cell, expanded, donor8	11941-126A6	45.52	101.76	18.75	0.50	0.50
Melanocyte - dark, donor1	11502-119F8	12.44	2.69	3.28	0.40	0.30
Melanocyte - dark, donor2	11582-120F7	10.04	10.04	2.08	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	32.82	62.30	11.59	0.72	0.29
Melanocyte - light, donor1	11274-116H5	16.69	19.98	4.23	0.24	0.71
Melanocyte - light, donor2	11351-117H1	18.43	23.89	2.73	0.68	0.00
Melanocyte - light, donor3	11423-118G1	7.81	8.67	5.20	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	31.13	32.80	6.56	0.83	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	19.09	59.17	5.65	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	27.59	81.96	12.86	2.41	0.27
Meningeal Cells, donor1	11493-119E8	19.73	16.13	7.82	1.12	0.25
Meningeal Cells, donor2	11573-120E7	13.64	15.41	3.52	0.00	0.00
Meningeal Cells, donor3	11654-122E7	21.03	19.56	8.56	0.90	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	9.12	6.27	3.14	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.03	24.05	5.64	0.20	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	1.31	0.00	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	12.92	0.00	2.87	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.21	14.82	4.24	1.06	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.58	14.58	3.52	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	11.21	1.76	2.20	1.10	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.88	2.19	1.46	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.59	1.23	1.64	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	19.81	5.96	2.91	0.28	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.60	4.46	0.00	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	14.60	15.53	6.18	2.24	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.04	2.97	1.19	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	5.76	3.20	1.92	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	14.53	3.54	2.13	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	9.07	8.44	4.38	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	7.26	3.63	2.18	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	27.84	18.56	7.42	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	13.51	14.51	5.51	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	25.29	17.99	5.71	0.22	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	6.75	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	19.95	11.08	2.96	0.25	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	14.13	8.83	2.06	0.00	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	18.91	10.23	2.48	0.00	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	12.65	5.19	1.24	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	18.02	9.01	1.00	0.00	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	17.22	6.98	1.86	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	0.00	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.43	10.77	3.45	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	11.88	5.94	0.40	0.00	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	5.31	1.77	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.88	6.46	0.76	0.00	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	5.26	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	9.76	9.97	2.12	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.33	7.15	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	1.68	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	8.28	5.77	2.26	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.61	7.13	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.42	0.55	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	3.68	6.91	0.92	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.36	4.21	1.26	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.71	6.32	1.02	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.01	8.58	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.78	3.78	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.29	6.79	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.11	3.55	1.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	4.89	3.26	0.82	0.00	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.35	2.94	0.59	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	2.18	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.77	2.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	9.61	4.80	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.01	4.51	2.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.01	3.50	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	1.28	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.19	6.94	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	2.78	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	8.21	4.79	1.37	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.91	1.42	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	8.42	5.89	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	8.31	2.08	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	3.50	0.58	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.64	6.33	0.60	0.30	1.81
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.94	8.35	2.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.83	2.28	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.32	5.39	1.24	0.00	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.77	3.37	1.81	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.44	3.86	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7.62	3.18	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.41	2.67	0.80	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.27	6.59	2.10	0.00	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.61	5.37	1.84	0.00	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.60	8.28	1.27	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	9.51	3.76	1.99	0.00	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	6.83	4.55	1.52	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.80	5.11	1.14	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	15.73	5.65	1.23	0.00	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	3.91	0.65	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	8.53	2.65	1.76	0.00	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	14.42	8.65	1.44	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.95	14.01	4.95	0.00	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	12.51	6.25	1.19	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	5.35	3.56	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.76	16.76	2.30	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	16.83	9.47	4.21	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	25.50	23.52	2.77	0.00	1.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.97	4.66	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	29.29	11.64	3.38	0.75	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	13.05	7.19	2.93	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	22.17	15.04	3.17	0.11	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	6.63	5.16	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	11.36	15.39	3.66	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	14.00	0.00	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.41	8.02	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	11.11	3.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.90	6.75	1.69	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	23.15	2.72	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	3.18	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	10.57	3.02	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	45.68	0.00	17.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	35.89	26.10	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	24.78	17.88	6.68	0.43	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	24.56	17.77	4.70	1.57	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.69	3.34	1.33	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.86	2.50	1.25	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	21.87	9.89	4.37	0.76	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	12.77	7.98	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.28	6.80	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	33.08	18.38	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	13.39	7.95	1.26	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	19.52	3.49	1.63	0.70	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.38	7.03	2.16	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	16.40	13.88	3.57	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	44.54	33.40	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.93	6.95	2.48	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.56	10.29	1.35	1.35	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.20	8.84	2.27	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.96	5.55	3.59	0.16	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	14.22	12.21	4.37	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.14	11.67	4.77	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	11.41	10.81	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.72	18.38	5.25	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.22	6.34	2.93	0.33	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	17.46	19.40	6.35	0.18	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.14	11.25	4.22	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	17.47	8.73	1.84	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	13.50	11.57	4.18	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	20.00	14.14	3.45	3.10	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	35.40	48.04	7.59	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	15.82	12.92	4.46	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.51	5.93	4.23	0.00	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.61	9.26	2.37	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.74	4.29	3.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	90.28	18.06	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	13.00	6.33	3.67	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.72	10.82	1.80	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.87	6.75	3.57	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	10.22	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.89	9.46	3.41	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.06	5.54	2.28	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.38	3.92	0.87	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	13.57	21.71	2.26	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	15.87	7.94	6.17	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.95	9.31	3.99	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	16.37	11.91	6.94	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.48	3.45	2.30	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	23.89	12.10	6.05	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	15.47	17.24	3.98	0.00	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	14.23	3.39	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	25.55	15.33	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.36	4.88	3.66	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.79	3.78	0.63	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.28	9.99	3.93	0.61	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.87	9.49	6.33	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	26.07	17.00	4.53	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	10.12	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	22.49	9.32	2.98	0.62	0.25
Myoblast, donor2	11322-117D8	16.49	8.25	2.11	0.00	0.38
Myoblast, donor3	11398-118D3	25.56	11.10	5.04	0.50	2.02
NK T cell leukemia cell line:KHYG-1	10777-110G3	4.09	3.94	2.33	0.58	0.00
Natural Killer Cells, donor1	11230-116C6	8.61	98.10	9.23	0.62	0.00
Natural Killer Cells, donor2	11311-117C6	9.05	84.74	5.73	0.90	0.30
Natural Killer Cells, donor3	11387-118C1	10.68	93.13	6.81	0.92	0.92
Neural stem cells, donor1	11275-116H6	26.13	30.12	17.78	5.08	0.73
Neural stem cells, donor2	11352-117H2	82.80	21.18	21.18	3.85	1.93
Neurons, donor1	11494-119E9	33.00	23.90	9.10	1.14	0.00
Neurons, donor2	11574-120E8	35.01	16.07	11.01	0.00	0.88
Neurons, donor3	11655-122E8	28.78	11.51	10.69	2.47	0.00
Neutrophils, donor1	11233-116C9	50.11	28.77	8.35	4.64	0.93
Neutrophils, donor2	11314-117C9	55.08	34.79	5.80	8.70	0.00
Neutrophils, donor3	11390-118C4	97.73	50.70	11.61	2.44	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	11.99	10.57	5.46	2.26	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	5.86	9.12	1.63	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	11.63	4.81	1.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	8.40	14.59	2.75	0.55	0.55
Olfactory epithelial cells, donor2	11934-125I8	12.01	13.03	3.04	0.14	0.00
Olfactory epithelial cells, donor3	11935-125I9	10.56	10.56	2.72	0.00	0.57
Olfactory epithelial cells, donor4	11936-126A1	19.48	10.03	3.90	0.19	0.97
Oligodendrocyte - precursors, donor1	11496-119F2	36.11	13.84	4.21	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	16.80	12.34	2.77	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	1.14	4.57	1.14	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	9.93	8.07	1.86	0.00	0.00
Osteoblast, donor1	11277-116H8	8.40	5.67	2.74	2.15	0.00
Osteoblast, donor2	11354-117H4	19.66	9.13	5.62	0.00	0.70
Osteoblast, donor3	11426-118G4	15.46	3.20	2.84	0.36	1.07
Pancreatic stromal cells, donor1	11249-116E7	19.80	10.45	5.05	3.29	0.25
Pericytes, donor1	11491-119E6	3.34	5.01	1.00	0.56	0.00
Pericytes, donor2	11571-120E5	4.98	5.21	2.26	0.23	0.23
Pericytes, donor3	11652-122E5	9.36	2.64	0.61	0.00	0.61
Perineurial Cells, donor1	11499-119F5	15.37	10.40	6.78	0.34	0.34
Perineurial Cells, donor2	11579-120F4	15.27	15.00	4.14	1.38	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	24.54	50.68	5.74	0.00	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	13.71	33.79	4.65	0.00	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	14.75	32.87	3.88	0.39	0.26
Placental Epithelial Cells, donor1	11278-116H9	16.98	4.78	1.20	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	8.87	5.54	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.91	4.91	2.75	0.20	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.91	5.70	0.63	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	22.70	17.63	2.25	0.19	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	29.11	17.10	7.44	0.65	0.78
Preadipocyte - breast, donor2	11328-117E5	15.08	9.01	1.13	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	29.94	21.31	5.01	0.32	1.07
Preadipocyte - omental, donor2	11329-117E6	25.32	22.26	4.80	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	28.08	12.75	3.87	1.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	14.76	2.95	1.97	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	8.91	8.60	1.84	1.54	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	22.67	9.56	5.31	1.42	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	6.47	9.54	2.89	0.68	0.34
Preadipocyte - visceral, donor1	11280-116I2	25.43	10.43	3.45	2.51	0.65
Preadipocyte - visceral, donor2	11357-117H7	15.65	15.19	1.84	1.38	1.38
Preadipocyte - visceral, donor3	11429-118G7	12.85	6.79	2.51	0.94	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	49.18	19.76	7.84	1.36	0.45
Prostate Epithelial Cells, donor2	11331-117E8	19.77	5.15	3.39	1.22	0.27
Prostate Epithelial Cells, donor3	11404-118D9	37.35	1.04	1.41	0.24	1.47
Prostate Stromal Cells, donor1	11254-116F3	26.54	9.11	3.42	1.48	0.46
Prostate Stromal Cells, donor2	11332-117E9	20.44	9.68	3.23	1.08	0.54
Prostate Stromal Cells, donor3	11405-118E1	13.97	8.55	3.02	1.15	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	15.69	4.01	1.09	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	29.46	4.57	2.43	0.35	0.76
Renal Epithelial Cells, donor1	11517-119H5	9.64	2.03	1.52	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	12.09	0.71	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	24.45	6.03	4.66	0.11	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.89	2.04	1.36	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.32	2.43	0.81	0.40	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	14.65	4.00	3.11	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	2.00	0.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	7.04	2.86	1.32	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	7.52	7.52	3.13	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	3.33	1.39	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	28.72	5.10	3.22	0.27	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	15.18	4.64	2.11	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	10.22	2.12	1.16	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	32.93	12.45	4.15	4.15	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	18.19	8.53	5.40	2.56	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	10.29	9.26	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.61	14.80	6.77	1.25	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	30.34	7.62	5.08	0.40	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	9.83	6.25	1.79	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	21.46	24.22	8.81	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	15.08	12.18	5.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	20.54	11.05	7.28	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	11.22	5.46	3.77	0.10	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	15.50	8.81	6.47	0.22	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	20.34	11.66	7.81	0.25	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	13.17	6.53	4.20	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	15.25	11.33	6.24	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	11.91	6.16	4.38	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	13.31	6.35	5.75	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	13.44	6.09	5.73	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	15.78	7.46	4.73	0.57	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	12.34	6.98	4.29	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	11.73	6.20	4.87	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	12.04	7.26	3.44	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	15.00	6.15	7.17	0.09	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	20.67	17.29	9.96	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	15.92	6.64	3.98	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	13.92	9.05	4.19	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	12.99	8.02	5.54	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	15.27	8.65	3.10	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	16.54	6.73	4.48	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	15.04	7.18	5.13	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	13.67	5.29	2.92	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	13.24	5.89	4.66	0.25	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	11.28	8.33	3.49	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	17.22	5.90	2.83	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	13.10	8.73	6.15	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	14.50	8.65	4.44	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	14.72	7.26	5.18	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	13.72	11.06	4.87	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	14.62	8.36	3.97	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	19.11	8.61	5.25	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	13.28	6.47	5.28	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	16.19	7.90	5.78	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	17.02	9.46	3.78	0.52	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	15.36	8.50	4.53	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	14.12	8.87	7.72	0.16	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	15.51	8.01	4.09	0.17	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	16.72	10.50	4.88	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	16.26	9.86	5.86	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	12.17	8.85	4.01	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	9.76	6.19	5.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	13.91	11.29	9.07	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.38	7.25	4.33	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	9.78	8.38	5.59	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	8.16	9.37	3.02	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	10.65	11.50	5.02	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	19.50	16.16	10.77	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	10.34	3.04	9.73	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.95	5.43	6.33	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	12.44	6.11	6.56	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	13.48	7.49	7.79	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	15.11	10.98	6.02	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	11.10	8.75	4.91	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	13.22	7.21	3.61	0.00	0.00
Schwann Cells, donor1	11498-119F4	6.02	2.44	1.32	0.00	0.38
Schwann Cells, donor2	11578-120F3	10.21	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	11.17	10.30	3.72	0.00	0.44
Sebocyte, donor1	11220-116B5	38.34	8.76	4.38	0.00	0.55
Sebocyte, donor2	11301-117B5	20.68	4.60	1.84	0.92	0.00
Sebocyte, donor3	11378-118B1	15.25	4.53	1.86	0.62	0.00
Sertoli Cells, donor1	11255-116F4	29.82	16.57	6.63	0.00	0.00
Sertoli Cells, donor2	11333-117F1	22.59	19.77	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	23.14	4.31	4.75	1.23	0.53
Skeletal Muscle Cells, donor2	11358-117H8	5.06	4.34	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	16.72	3.34	4.18	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	19.64	7.85	2.36	0.79	0.47
Skeletal Muscle Cells, donor5	11455-119A6	17.24	5.80	1.78	0.45	0.45
Skeletal Muscle Cells, donor6	11459-119B1	25.24	5.39	4.31	0.46	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	17.01	16.38	4.91	1.13	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	14.41	6.85	3.57	0.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	22.82	9.13	4.96	0.79	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	17.36	13.40	6.49	1.77	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.86	2.90	2.17	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.26	3.85	2.06	0.28	0.55
Skin - palm, donor1	10286-104F7	26.86	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	14.85	2.16	0.72	0.00	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	155.40	26.99	13.09	4.09	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.46	3.76	1.04	0.13	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	37.67	5.84	2.78	0.14	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	21.94	3.80	1.27	0.00	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	113.55	33.20	10.78	0.00	4.86
Small Airway Epithelial Cells, donor3	11406-118E2	38.90	3.22	1.05	0.15	2.17
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	17.90	4.94	0.31	0.62	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	39.57	10.89	3.78	0.67	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	16.46	2.94	2.35	1.18	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	11.49	3.54	1.77	0.22	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	19.30	2.36	0.79	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.91	3.86	6.95	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	9.01	7.01	4.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	18.90	2.79	1.33	0.13	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	10.20	7.54	2.66	0.66	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	22.15	5.51	3.58	0.13	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.37	14.33	7.16	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	21.85	16.83	6.79	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.52	8.68	3.27	0.28	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	11.71	1.30	0.33	0.98	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.92	4.26	2.44	1.22	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.15	8.08	2.02	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.40	3.34	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	21.38	10.47	3.24	1.18	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	16.36	12.91	4.30	2.80	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.85	8.19	2.83	0.73	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	17.32	3.71	2.47	0.46	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	3.23	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.63	6.28	0.90	0.00	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.56	2.73	1.02	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.44	19.87	5.26	1.49	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	30.59	4.73	2.11	0.50	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	17.07	6.83	3.41	0.68	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	19.32	4.83	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	35.24	4.50	5.03	1.85	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.17	7.99	3.73	0.67	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	15.78	10.64	1.88	0.88	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	9.64	10.91	3.55	0.76	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	22.31	7.99	4.52	2.56	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	5.25	6.00	0.75	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	3.88	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	10.70	6.98	1.40	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.60	5.05	1.51	1.01	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.18	3.76	1.25	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.95	1.47	0.59	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	25.16	5.08	2.67	1.00	1.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	9.81	5.14	4.20	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	17.13	3.45	2.16	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.98	4.84	2.04	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.21	3.20	1.50	0.38	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	22.08	9.36	5.87	1.26	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.32	5.28	2.26	0.50	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	3.33	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	17.86	2.94	1.96	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.21	14.36	5.08	1.55	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	18.43	5.85	2.34	2.93	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.02	7.58	3.11	1.17	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	19.31	9.78	2.38	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.60	18.97	1.86	1.86	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	22.64	11.14	3.59	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	21.58	7.38	1.42	0.57	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	18.51	11.03	1.58	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	17.01	10.41	3.56	1.27	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	10.38	3.99	0.80	1.60	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	12.54	10.87	2.51	1.67	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	16.50	11.00	1.83	0.00	0.46
Synoviocyte, donor1	11291-117A4	14.31	12.46	3.20	1.01	0.50
Synoviocyte, donor2	11368-117I9	10.56	6.87	1.68	0.67	0.34
Synoviocyte, donor3	11440-118H9	15.19	7.60	1.79	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	11.08	4.65	2.14	1.07	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.63	0.69	1.39	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	34.12	4.37	1.51	0.29	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	10.44	1.55	1.93	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	14.32	1.72	1.15	0.57	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	26.94	9.60	4.06	0.12	0.98
Urethra, donor2	10319-105A4	23.38	3.60	1.80	0.00	1.80
Urothelial Cells, donor1	11520-119H8	11.69	2.66	0.00	0.00	0.27
Urothelial Cells, donor2	11600-120H7	10.01	4.01	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	6.19	1.15	0.92	0.69	0.00
Urothelial cells, donor0	11216-116B1	29.20	10.92	4.01	0.22	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	41.82	28.47	7.12	247.36	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	48.61	38.60	5.72	260.19	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	17.80	13.69	4.11	21.22	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	28.24	16.53	4.48	243.79	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	29.63	16.85	5.81	220.21	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	30.20	20.82	4.16	155.14	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	39.47	27.53	6.42	255.15	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.00	16.43	0.91	28.30	0.00
Wilms' tumor cell line:G-401	10809-111A8	19.37	20.11	8.88	0.74	0.37
Wilms' tumor cell line:HFWT	10597-108E3	30.80	1.76	5.28	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	39.10	3.07	1.96	0.28	0.56
achilles tendon, donor2	10292-104G4	10.33	2.07	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	12.49	15.04	8.41	2.04	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	10.22	15.09	9.29	0.93	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	14.01	28.61	11.40	1.78	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	24.22	73.47	11.97	4.63	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	14.90	14.34	4.22	1.41	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	14.59	28.34	7.61	0.85	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	17.15	32.94	4.08	1.09	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	20.71	22.91	7.05	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	26.54	67.38	8.58	3.27	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	11.65	11.65	4.66	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	6.44	2.58	0.74	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	62.41	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	10.22	18.82	6.04	0.46	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	11.91	5.95	5.18	0.26	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	13.15	9.64	2.92	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	12.08	6.51	3.25	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	17.27	5.35	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	12.58	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	25.18	5.55	5.12	0.85	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	22.44	2.12	4.25	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	22.87	3.13	3.61	0.24	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	13.14	4.68	1.78	0.22	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	29.69	12.34	4.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	13.01	27.87	5.57	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	36.91	38.80	9.42	1.13	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	22.24	41.87	12.65	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	11.25	18.74	9.37	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	36.03	9.89	5.65	0.24	0.94
adipose tissue, adult, pool1	10010-101C1	30.87	10.08	4.34	0.16	1.55
adipose, donor1	10184-103D4	23.46	53.95	29.32	8.21	0.59
adipose, donor2	10185-103D5	17.03	9.73	4.87	1.22	0.41
adipose, donor3	10186-103D6	9.53	11.16	8.17	2.18	0.00
adipose, donor4	10187-103D7	9.53	14.73	6.07	3.47	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	27.93	1.89	4.42	0.00	0.47
adrenal gland, adult, pool1	10081-102A9	18.19	7.28	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	18.94	7.20	4.00	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	21.08	9.29	6.43	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	36.86	16.23	4.64	0.70	2.09
amniotic membrane cells, donor2	12236-129G4	21.98	8.45	3.72	1.35	0.34
amniotic membrane cells, donor3	12237-129G5	38.30	7.07	3.83	0.00	5.01
amygdala - adult, donor10196	10167-103B5	41.50	16.60	14.23	0.00	2.37
amygdala, adult, donor10252	10151-102I7	39.34	9.53	9.12	0.61	1.62
amygdala, newborn, donor10223	10360-105E9	30.99	17.75	4.20	0.00	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	27.38	16.43	3.31	3.69	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	5.29	4.63	2.43	0.00	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	14.70	18.71	9.02	0.33	0.33
aorta, adult, pool1	10052-101G7	27.65	11.96	4.12	0.20	0.98
appendix, adult	10189-103D9	27.17	8.15	3.88	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	22.70	14.79	8.25	0.00	1.03
artery, adult	10190-103E1	28.53	4.08	2.72	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	14.49	7.82	5.36	0.14	0.14
b cell line:RPMI1788	10427-106D4	14.87	5.50	3.42	0.59	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	25.25	7.49	3.88	1.11	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	22.03	5.36	1.98	0.10	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	47.87	6.19	3.35	0.17	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	12.86	4.47	1.68	0.00	1.68
bladder, adult, pool1	10011-101C2	29.33	4.67	2.61	0.43	1.74
blood, adult, pool1	10053-101G8	4.43	17.72	0.00	24.36	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	12.85	11.99	1.71	0.00	0.00
bone marrow, adult	10192-103E3	24.29	11.47	4.05	0.00	0.67
brain, adult, donor1	10084-102B3	39.98	8.20	4.10	1.03	2.05
brain, adult, pool1	10012-101C3	46.66	14.25	8.35	0.11	2.45
brain, fetal, pool1	10085-102B4	18.70	24.04	10.69	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	27.75	5.29	3.96	0.33	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	22.47	5.62	4.87	1.62	0.50
breast, adult, donor1	10080-102A8	18.94	3.79	1.89	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	34.68	2.79	3.43	0.25	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	12.37	3.40	1.86	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	29.93	10.13	7.83	2.53	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	21.06	1.69	1.94	0.73	0.48
carcinoid cell line:NCI-H1770	10703-109H1	19.75	1.88	4.70	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	14.77	4.27	3.06	0.66	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	9.51	6.65	5.07	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	25.82	15.44	7.72	0.27	0.27
caudate nucleus - adult, donor10196	10177-103C6	46.05	19.57	9.21	0.00	6.91
caudate nucleus, adult, donor10252	10164-103B2	28.45	17.23	7.20	0.00	2.84
caudate nucleus, adult, donor10258	10379-105H1	20.63	17.58	6.11	0.00	2.29
caudate nucleus, newborn, donor10223	10354-105E3	26.00	22.34	4.76	0.00	1.46
cerebellum - adult, donor10196	10173-103C2	67.01	40.79	40.79	2.91	5.83
cerebellum, adult, donor10252	10166-103B4	83.27	29.68	19.86	0.64	4.06
cerebellum, adult, pool1	10083-102B2	49.67	18.97	13.45	0.69	1.38
cerebellum, newborn, donor10223	10357-105E6	54.80	59.78	19.93	0.00	0.83
cerebral meninges, adult	10188-103D8	37.06	9.33	6.81	0.00	0.76
cerebrospinal fluid, donor2	10294-104G6	11.69	3.65	4.39	0.73	1.46
cervical cancer cell line:D98-AH2	10552-107I3	35.95	3.02	3.31	0.29	0.72
cervical cancer cell line:ME-180	10553-107I4	30.16	6.13	2.32	0.00	0.50
cervix, adult, pool1	10013-101C4	34.33	7.24	4.62	0.21	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	29.40	13.10	8.36	0.28	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	3.92	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	16.65	4.97	5.22	0.25	0.00
choriocarcinoma cell line:SCH	10785-110H2	28.34	2.09	3.33	0.12	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	16.13	1.90	0.71	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	24.50	9.97	3.13	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	22.07	13.22	6.46	0.60	1.09
chorionic membrane cells, donor3	12240-129G8	26.92	10.99	4.95	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	6.06	25.25	6.06	6.06	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	19.02	28.05	8.64	0.96	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	23.23	19.64	6.97	1.27	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	26.96	11.04	4.37	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	27.57	11.85	5.56	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	24.84	13.85	6.92	0.00	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	32.68	14.13	10.31	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	49.00	40.40	14.33	1.30	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	11.89	2.06	2.51	0.46	0.23
clear cell carcinoma cell line:TEN	10636-108I6	23.42	6.42	3.64	1.21	1.21
colon carcinoma cell line:CACO-2	10513-107D9	58.57	31.30	15.38	2.75	0.37
colon carcinoma cell line:COLO-320	10420-106C6	35.73	15.96	13.30	0.00	0.00
colon, adult, donor1	10082-102B1	41.65	8.33	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	20.21	5.76	4.00	0.24	0.47
colon, fetal, donor1	10070-101I7	12.98	8.03	3.71	0.00	1.85
common myeloid progenitor CMP, donor1	12130-128D6	41.25	91.67	18.33	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	16.57	12.32	4.25	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	5.89	6.94	1.96	0.75	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	9.02	9.02	4.65	1.27	0.14
corpus callosum, adult, pool1	10042-101F6	86.13	14.26	13.60	0.11	3.54
cruciate ligament, donor2	10295-104G7	29.18	7.29	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	21.67	6.42	4.01	0.00	0.00
diencephalon, adult	10193-103E4	40.56	10.56	5.76	0.00	2.16
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	9.64	8.27	3.67	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	14.10	2.05	2.56	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	14.44	6.02	1.93	0.72	0.00
ductus deferens, adult	10196-103E7	19.93	5.48	1.50	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	34.57	8.64	2.88	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	24.28	12.51	3.68	0.00	0.74
dura mater, adult, donor1	10041-101F5	35.93	26.76	7.76	1.98	1.90
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	12.88	9.10	7.33	1.55	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	22.78	7.31	8.31	0.72	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	17.88	2.47	3.08	0.00	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	15.74	4.24	2.42	0.61	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.36	3.40	2.47	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	17.08	5.25	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	20.78	9.05	5.70	0.00	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	50.93	10.15	9.42	1.27	4.35
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	10.94	5.31	1.93	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	19.56	7.67	5.00	0.22	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	26.07	8.47	3.52	0.44	0.44
epididymis, adult	10197-103E8	22.81	6.07	2.72	0.00	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	11.18	1.24	1.95	0.18	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	13.76	19.66	5.51	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	19.26	7.47	3.54	0.52	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	14.86	6.10	2.76	0.69	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	18.04	5.60	5.15	0.90	0.45
esophagus, adult, pool1	10015-101C6	24.74	5.31	1.91	0.21	1.06
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	31.18	17.28	12.40	3.63	0.63
eye - muscle inferior rectus, donor1	10272-104E2	43.46	4.83	7.24	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	14.73	2.10	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	25.30	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	29.81	4.59	1.15	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	11.66	8.74	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	34.32	10.42	5.08	0.00	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	9.49	4.49	2.44	0.13	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	30.15	5.70	3.80	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	73.84	20.27	13.32	0.09	3.10
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	28.22	3.60	4.80	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	58.61	18.10	10.61	0.00	1.55
gall bladder, adult	10198-103E9	23.42	4.83	1.21	0.00	0.48
gamma delta positive T cells, donor1	11937-126A2	9.13	27.38	10.20	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	7.84	44.82	7.47	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	9.08	3.17	1.90	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	27.27	4.26	2.32	0.00	0.97
gastric cancer cell line:AZ521	10549-107H9	20.82	8.36	5.57	0.98	0.49
gastric cancer cell line:GSS	10560-108A2	36.61	0.92	2.75	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.29	6.63	8.91	0.46	0.69
giant cell carcinoma cell line:LU65	10487-107B1	30.75	1.61	1.38	0.57	1.26
giant cell carcinoma cell line:Lu99B	10433-106E1	45.49	19.45	11.76	0.98	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	22.20	4.24	2.49	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	18.89	31.67	7.60	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	22.61	27.10	11.66	0.42	0.28
glioblastoma cell line:T98G	10485-107A8	11.37	9.05	4.64	2.87	0.33
glioma cell line:GI-1	10413-106B8	22.84	30.46	9.66	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	37.17	6.56	5.10	0.00	2.92
globus pallidus, adult, donor10252	10161-103A8	58.09	12.94	7.81	0.00	1.71
globus pallidus, adult, donor10258	10367-105F7	43.81	9.58	6.85	0.00	4.11
globus pallidus, newborn, donor10223	10364-105F4	20.78	8.53	5.33	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	14.68	19.58	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	15.04	15.04	3.52	0.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	21.12	9.18	6.89	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	16.00	11.89	6.86	2.74	0.00
hIPS +CCl2, biol_rep3	14385-156C2	11.59	9.02	5.15	0.00	0.00
hIPS, biol_rep1	14380-156B6	11.50	18.68	5.75	0.00	0.00
hIPS, biol_rep2	14381-156B7	14.40	12.35	5.49	2.74	0.00
hIPS, biol_rep3	14382-156B8	30.90	6.62	6.62	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	13.22	6.61	3.74	0.29	0.00
heart - mitral valve, adult	10205-103F7	37.37	11.06	5.68	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	35.30	3.40	2.61	0.26	1.31
heart - tricuspid valve, adult	10207-103F9	28.31	2.50	0.00	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	25.51	3.88	4.49	0.20	0.82
heart, adult, diseased, donor1	10051-101G6	33.21	6.39	4.26	0.00	0.85
heart, adult, pool1	10016-101C7	22.77	4.60	1.61	0.00	0.00
heart, fetal, pool1	10046-101G1	50.11	16.63	10.47	0.62	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	18.20	8.64	5.86	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	10.70	8.32	4.76	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	21.77	30.17	12.04	1.77	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	25.49	34.35	12.26	1.09	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	25.26	34.66	11.62	0.81	0.30
hepatoma cell line:Li-7	10484-107A7	27.58	6.34	5.45	0.22	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	10.85	2.41	2.31	0.30	0.20
hippocampus - adult, donor10196	10169-103B7	35.96	17.98	8.52	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	45.11	13.67	8.78	0.00	2.25
hippocampus, adult, donor10258	10374-105G5	49.30	8.47	5.48	0.00	3.98
hippocampus, newborn, donor10223	10363-105F3	29.61	9.87	5.29	0.00	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	19.53	28.08	9.16	3.66	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	15.12	10.41	6.09	0.98	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	12.69	12.44	5.08	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.59	16.92	7.33	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	12.39	24.53	7.23	1.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	13.67	27.33	8.73	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	17.23	16.35	9.34	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	16.80	16.80	9.69	0.65	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	12.51	17.52	6.67	2.09	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	14.21	20.84	7.10	1.89	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	10.93	18.16	5.95	1.45	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	12.79	16.16	11.45	2.69	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	13.14	13.14	5.79	1.41	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	14.74	12.77	4.91	2.46	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	20.07	20.07	9.60	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	16.80	30.35	11.07	2.10	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	15.70	31.40	11.34	3.05	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	19.99	30.99	15.99	2.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	17.33	11.12	8.29	0.57	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	13.19	11.37	6.82	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	18.48	11.59	7.83	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	8.98	21.07	8.00	0.82	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8.13	22.64	8.71	0.58	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	5.98	10.46	7.47	0.60	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	12.56	12.93	5.54	1.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	12.55	14.83	7.99	1.43	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	15.52	13.88	5.72	2.45	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	17.60	27.81	10.56	1.41	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	17.10	23.44	7.60	1.27	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.95	18.76	6.05	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.93	12.93	7.24	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	11.95	13.95	7.31	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	8.21	12.31	6.16	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	10.48	18.92	10.99	1.28	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	13.63	15.90	4.54	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	13.78	15.12	4.70	1.68	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.77	11.59	6.52	0.48	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	18.27	15.60	5.35	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	11.22	10.24	4.39	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	13.75	28.12	14.06	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	91.09	178.93	71.57	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	20.52	31.44	10.92	1.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	10.40	15.32	3.83	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	19.90	9.77	4.70	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	13.52	9.25	4.98	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	13.13	14.32	9.55	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	18.55	26.00	11.78	2.30	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	5.12	14.82	2.69	1.89	0.00
immature langerhans cells, donor1	11904-125F5	50.12	264.67	25.43	1.45	0.97
immature langerhans cells, donor2	11905-125F6	26.14	42.78	7.13	1.58	0.00
insula, adult, pool1	10039-101F3	74.00	21.29	16.66	0.00	3.50
keratoacanthoma cell line:HKA-1	10791-110H8	14.96	5.85	3.58	0.33	0.98
kidney, adult, pool1	10017-101C8	27.43	10.81	5.41	0.10	0.20
kidney, fetal, pool1	10045-101F9	32.54	10.68	7.50	0.35	1.34
large cell lung carcinoma cell line:IA-LM	10509-107D5	27.98	16.47	7.39	0.14	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.39	4.84	2.76	0.41	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	29.91	4.95	4.40	0.00	0.55
left atrium, adult, donor1	10079-102A7	23.43	7.63	1.09	0.00	0.54
left ventricle, adult, donor1	10078-102A6	30.34	4.55	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	10.67	3.56	2.46	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	10.42	8.26	1.08	1.08	0.00
leiomyoma cell line:15242A	10570-108B3	24.46	10.33	3.80	1.09	1.09
leiomyoma cell line:15425	10571-108B4	21.61	7.77	2.67	0.73	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	12.70	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	10.46	27.18	8.36	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	15.94	37.66	6.61	1.42	0.00
liposarcoma cell line:KMLS-1	10782-110G8	28.59	15.31	6.87	1.09	1.41
liposarcoma cell line:SW 872	10726-110A6	7.55	3.41	3.29	0.49	0.37
liver, adult, pool1	10018-101C9	15.40	2.11	3.57	0.00	0.49
liver, fetal, pool1	10086-102B5	18.81	2.82	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	37.48	5.69	6.12	0.00	1.02
locus coeruleus, adult, donor10252	10165-103B3	40.23	5.72	4.61	0.00	2.03
locus coeruleus, adult, donor10258	10375-105G6	30.47	7.34	3.39	0.00	2.26
locus coeruleus, newborn, donor10223	10362-105F2	34.91	15.98	9.25	0.42	0.84
lung adenocarcinoma cell line:A549	10499-107C4	21.87	5.81	3.32	0.28	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	16.55	11.72	6.89	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	15.29	3.30	3.16	0.00	0.66
lung, adult, pool1	10019-101D1	30.95	7.44	2.36	0.24	0.83
lung, fetal, donor1	10068-101I5	126.44	52.23	16.27	1.71	3.71
lung, right lower lobe, adult, donor1	10075-102A3	35.28	9.62	2.75	0.46	2.75
lymph node, adult, donor1	10077-102A5	16.57	11.36	2.84	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	6.58	3.07	2.85	1.53	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	10.11	36.68	12.98	0.91	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.94	5.95	5.10	0.85	0.85
mature adipocyte, donor1	12231-129F8	17.32	3.55	2.22	0.00	1.33
mature adipocyte, donor2	12232-129F9	24.49	4.57	2.28	0.00	1.25
mature adipocyte, donor3	12233-129G1	15.41	4.50	2.13	0.00	0.47
mature adipocyte, donor4	12234-129G2	19.74	5.79	2.90	0.00	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	15.01	3.57	4.29	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	41.74	20.30	13.54	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	52.60	14.16	8.46	0.00	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	45.43	9.21	9.85	0.00	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	43.93	38.38	12.79	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	51.98	19.58	9.62	0.17	1.86
medial temporal gyrus, adult, donor10252	10156-103A3	54.12	9.76	8.70	0.00	1.70
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	9.63	5.78	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	43.06	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	28.36	17.23	8.97	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	32.45	5.19	2.60	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	44.58	10.68	7.12	0.15	2.17
medulla oblongata, adult, pool1	10038-101F2	60.57	13.06	9.71	0.00	3.18
medulla oblongata, newborn, donor10223	10361-105F1	30.55	5.55	1.74	0.00	1.04
medulloblastoma cell line:D283 Med	10838-111E1	23.03	21.26	8.41	0.89	0.22
medulloblastoma cell line:ONS-76	10759-110E3	13.21	2.57	2.81	0.24	0.37
melanoma cell line:COLO 679	10514-107E1	12.51	18.40	6.61	0.14	0.00
melanoma cell line:G-361	10465-106H6	25.25	12.76	4.89	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	12.12	3.80	0.90	0.00	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	66.97	36.13	17.62	3.52	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	17.11	5.96	4.67	0.52	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	13.96	11.97	4.30	0.77	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	9.27	14.36	2.91	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.01	8.70	2.48	1.66	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.14	10.54	2.53	1.12	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	14.06	12.32	2.89	0.58	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.05	7.63	3.47	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	22.31	7.04	3.78	0.17	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	19.90	7.82	2.42	0.23	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.32	13.66	4.38	1.33	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	20.53	12.15	5.27	1.08	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	20.63	13.09	5.12	0.14	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	19.76	6.59	2.96	0.33	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.71	11.07	4.15	0.14	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	13.96	6.98	4.54	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	22.05	4.70	3.06	0.20	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.13	8.63	2.16	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	13.86	12.62	4.24	0.10	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	19.61	12.31	3.19	0.23	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	40.70	10.91	5.87	1.26	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.90	9.56	3.59	0.15	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	16.19	11.55	4.46	0.18	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.03	10.31	3.31	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	22.03	10.30	2.00	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.84	10.10	9.68	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	8.68	6.85	1.37	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.30	5.12	2.30	1.79	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	17.01	5.24	2.36	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.63	4.01	3.39	0.92	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.94	8.71	2.12	0.00	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.14	7.45	3.38	1.35	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.97	7.47	1.96	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.90	6.02	1.85	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	11.54	4.04	2.31	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	11.38	6.47	0.89	0.89	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.50	6.25	1.20	1.20	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	14.67	2.93	2.20	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.41	7.05	1.68	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	10.64	3.68	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.45	3.87	2.15	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	8.77	3.90	1.30	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	7.27	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	14.39	4.26	1.60	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.00	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.16	3.89	2.72	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	2.10	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	1.99	1.99	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.34	4.74	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	9.75	2.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	7.60	6.33	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.97	7.59	2.41	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	10.75	4.30	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	13.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.89	4.48	1.22	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	3.97	7.94	0.79	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.31	8.25	1.77	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	6.23	6.23	0.94	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	4.01	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	9.46	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	2.57	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.88	4.13	2.07	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	6.43	3.96	3.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	4.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.90	3.82	1.27	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	11.28	0.81	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	4.36	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	1.27	1.27	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	17.60	2.43	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	4.52	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	4.12	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.10	5.75	2.38	0.00	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.66	4.22	1.62	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	2.04	3.06	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	9.28	5.42	1.55	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	51.97	11.58	8.27	0.94	2.83
mesothelioma cell line:ACC-MESO-4	10494-107B8	14.36	31.04	9.04	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	25.64	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.93	28.56	6.17	0.82	0.62
mesothelioma cell line:Mero-25	10850-111F4	24.74	19.97	2.95	0.45	0.45
mesothelioma cell line:Mero-41	10851-111F5	33.98	12.96	5.38	0.49	1.22
mesothelioma cell line:Mero-48a	10852-111F6	15.72	20.81	6.64	0.44	0.44
mesothelioma cell line:Mero-82	10853-111F7	15.51	12.61	5.26	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	14.13	19.92	4.94	0.51	0.00
mesothelioma cell line:Mero-84	10855-111F9	33.11	69.51	10.62	1.01	0.76
mesothelioma cell line:Mero-95	10856-111G1	13.25	27.33	4.97	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	18.39	8.94	0.50	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	28.60	41.45	8.33	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	59.28	62.52	14.86	0.68	1.37
mesothelioma cell line:NCI-H28	10845-111E8	18.83	14.25	4.83	0.25	0.25
mesothelioma cell line:No36	10857-111G2	36.21	22.18	5.87	0.33	0.98
mesothelioma cell line:ONE58	10858-111G3	33.87	40.64	5.96	1.08	0.27
migratory langerhans cells, donor1	11901-125F2	36.08	49.13	12.28	2.30	0.96
migratory langerhans cells, donor2	11902-125F3	36.27	33.58	10.62	3.42	0.85
migratory langerhans cells, donor3	11903-125F4	30.51	33.38	9.87	0.72	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.67	3.92	1.31	0.65	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	19.50	7.42	2.76	0.85	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	43.54	4.61	3.92	0.00	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	4.38	3.81	2.66	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	28.64	6.10	6.65	1.11	0.74
myeloma cell line:PCM6	10474-106I6	15.22	1.58	0.99	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	17.76	14.71	5.07	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	22.95	3.14	3.53	0.78	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	55.71	2.34	1.89	0.22	2.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	53.54	2.65	0.81	0.07	1.32
nasal epithelial cells, donor2	12227-129F4	36.43	8.28	3.31	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	40.03	34.97	31.29	1.15	0.23
neuroblastoma cell line:NB-1	10539-107G8	29.00	19.64	14.78	0.00	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	13.08	12.86	7.59	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	29.07	13.23	16.77	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.00	14.71	6.17	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	14.10	16.00	3.48	0.32	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	10.67	6.84	3.42	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	1.27	1.91	3.81	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	10.38	6.39	3.19	0.00	0.27
neutrophil PMN, donor1	12133-128D9	119.00	14.87	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	39.84	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	25.20	32.13	26.21	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	25.62	4.80	8.81	1.60	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	8.66	6.41	2.89	0.96	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.98	8.93	4.20	0.00	0.79
nucleus accumbens, adult, pool1	10037-101F1	63.93	19.59	14.06	0.19	3.19
occipital cortex - adult, donor10196	10172-103C1	55.63	18.54	16.48	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	49.92	11.00	6.44	0.00	1.88
occipital cortex, newborn, donor10223	10355-105E4	37.12	22.93	8.01	0.36	2.55
occipital lobe, adult, donor1	10076-102A4	57.73	13.91	8.40	0.26	1.84
occipital lobe, fetal, donor1	10073-102A1	58.36	23.17	20.60	0.43	3.00
occipital pole, adult, pool1	10036-101E9	47.30	10.88	9.15	0.00	2.76
olfactory region, adult	10195-103E6	41.27	12.23	6.11	0.19	2.67
optic nerve, donor1	10277-104E7	86.05	6.00	6.00	0.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	23.92	13.90	4.44	2.28	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	29.54	5.50	3.57	0.14	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	18.79	11.01	2.37	0.34	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	9.82	6.24	2.08	0.35	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	20.87	7.06	2.94	0.00	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	10.28	23.36	4.67	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	11.66	12.09	7.63	0.00	0.21
ovary, adult, pool1	10020-101D2	29.52	3.32	3.58	0.00	2.27
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	8.98	4.58	1.28	0.55	0.37
pancreas, adult, donor1	10049-101G4	44.21	7.53	2.82	0.00	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	6.43	3.07	2.52	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	21.81	14.14	3.07	0.17	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	44.38	20.37	5.80	0.50	1.16
paracentral gyrus, adult, pool1	10035-101E8	71.48	18.58	12.36	0.09	4.30
parietal cortex, adult, donor10258	10373-105G4	36.70	12.48	6.61	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	49.85	12.23	5.64	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	50.74	9.69	10.83	0.57	0.29
parietal lobe, adult, pool1	10034-101E7	67.24	17.27	14.36	0.09	3.52
parietal lobe, fetal, donor1	10072-101I9	64.01	29.10	20.37	0.00	5.82
parietal lobe, newborn, donor10223	10356-105E5	40.00	20.56	10.84	0.00	1.12
parotid gland, adult	10199-103F1	28.37	3.08	0.62	0.00	1.85
penis, adult	10200-103F2	19.34	5.91	2.15	0.00	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	25.47	6.88	4.28	0.56	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	16.17	3.21	1.46	0.15	0.44
pineal gland - adult, donor10196	10179-103C8	38.70	5.81	3.87	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	101.86	4.15	11.84	0.00	7.11
pineal gland, adult, donor10258	10377-105G8	66.47	6.90	8.15	0.00	3.76
pituitary gland - adult, donor10196	10180-103C9	39.46	9.11	6.07	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	81.30	8.34	12.51	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	34.90	5.96	4.26	0.00	2.55
placenta, adult, pool1	10021-101D3	24.83	10.32	4.95	0.43	1.40
plasma cell leukemia cell line:ARH-77	10840-111E3	7.95	7.15	4.63	0.93	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.77	12.45	6.69	0.62	0.62
pons, adult, pool1	10033-101E6	62.74	18.68	14.80	0.17	2.75
postcentral gyrus, adult, pool1	10032-101E5	55.97	13.69	11.33	0.17	3.57
promyelocytes/myelocytes PMC, donor1	12132-128D8	35.55	16.73	8.37	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	5.51	11.02	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	31.32	9.47	5.97	2.48	0.58
prostate cancer cell line:PC-3	10439-106E7	25.23	6.72	3.81	1.82	0.73
prostate, adult, pool1	10022-101D4	23.22	3.36	1.90	0.09	1.00
putamen, adult, donor10196	10176-103C5	26.68	23.61	8.73	0.00	0.71
putamen, adult, donor10252	10152-102I8	33.33	3.92	5.88	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	28.41	7.65	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	24.16	13.53	6.04	0.00	0.48
putamen, newborn, donor10223	10365-105F5	43.48	21.74	7.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	23.57	9.31	2.62	0.58	1.16
rectum, fetal, donor1	10067-101I4	37.56	23.65	18.08	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	26.92	2.54	2.12	0.64	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	33.55	8.70	4.56	1.66	0.41
retina, adult, pool1	10030-101E3	49.70	17.00	8.05	0.50	2.29
retinoblastoma cell line:Y79	10475-106I7	73.78	14.81	16.63	4.42	2.34
rhabdomyosarcoma cell line:KYM-1	10787-110H4	21.64	20.41	6.39	1.11	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	12.65	5.06	5.34	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	9.85	9.09	5.30	0.00	0.00
salivary acinar cells, donor1	11771-123I7	16.51	12.30	3.08	0.16	0.32
salivary acinar cells, donor2	11772-123I8	21.62	10.74	4.68	0.55	0.28
salivary acinar cells, donor3	11773-123I9	19.20	13.24	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	56.62	2.29	1.14	0.00	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	49.24	12.98	5.06	0.00	0.93
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	45.49	10.34	3.29	0.12	1.88
seminal vesicle, adult	10201-103F3	21.69	5.29	2.65	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	7.29	1.21	2.43	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	10.57	17.36	4.03	0.50	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	26.09	7.02	3.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	21.49	4.97	4.70	0.67	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	32.27	2.54	1.77	2.98	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	16.00	2.97	4.00	0.13	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	48.23	2.84	0.71	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	32.98	6.12	2.64	0.00	0.72
skeletal muscle, fetal, donor1	10066-101I3	15.08	7.04	7.04	2.01	0.00
skin, adult, donor1	10074-102A2	6.79	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	32.82	13.89	8.21	0.63	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	23.68	6.67	5.00	0.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	16.39	12.29	13.87	0.32	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	40.28	3.28	5.59	0.77	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	21.26	6.76	4.78	0.66	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	72.22	8.69	8.04	0.97	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	18.52	10.46	6.76	0.00	0.44
small intestine, adult, pool1	10024-101D6	26.52	7.64	4.06	0.24	0.60
small intestine, fetal, donor1	10064-101I1	23.10	5.65	5.16	0.00	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.90	2.56	2.56	2.05	0.00
smooth muscle, adult, pool1	10048-101G3	25.07	3.62	0.78	0.26	1.81
somatostatinoma cell line:QGP-1	10781-110G7	32.70	1.61	4.02	0.00	1.61
spinal cord - adult, donor10196	10181-103D1	39.69	8.95	7.34	0.00	1.84
spinal cord, adult, donor10252	10159-103A6	54.02	10.25	5.52	0.39	1.97
spinal cord, adult, donor10258	10369-105F9	56.73	9.69	5.53	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	39.64	15.25	15.86	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	50.05	13.78	4.13	0.00	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.85	5.23	2.09	0.00	0.30
spleen, adult, pool1	10025-101D7	15.64	9.58	4.30	1.10	0.33
spleen, fetal, pool1	10044-101F8	26.54	22.17	9.22	1.43	0.87
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	13.35	12.84	3.83	1.04	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	26.20	3.80	1.52	0.00	1.52
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	23.76	2.45	4.89	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	25.80	9.38	1.95	0.00	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	45.25	5.07	1.69	0.56	1.24
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.01	3.39	0.42	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	10.15	21.58	11.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	43.79	16.02	10.68	0.00	1.07
submaxillary gland, adult	10202-103F4	29.05	2.28	3.99	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	52.55	10.80	5.19	0.00	1.87
substantia nigra, adult, donor10258	10371-105G2	51.73	5.69	5.17	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	39.57	12.01	4.95	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	19.72	25.91	15.59	0.23	0.46
temporal lobe, adult, pool1	10031-101E4	46.12	13.48	9.32	0.08	1.78
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	67.67	17.09	20.66	0.00	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	47.03	17.58	8.35	0.00	1.76
tenocyte, donor1	11763-123H8	13.27	5.59	2.79	0.70	0.35
tenocyte, donor2	11765-123I1	12.97	8.39	1.91	0.00	0.00
tenocyte, donor3	11768-123I4	14.46	5.56	2.97	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	40.28	16.83	14.96	1.36	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	19.89	37.77	14.80	3.70	0.15
teratocarcinoma cell line:PA-1	10807-111A6	18.60	18.91	8.83	1.39	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	22.72	18.41	6.86	0.51	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	28.36	29.88	12.10	0.76	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	41.88	65.66	11.78	7.42	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	18.24	4.56	2.61	0.33	0.65
testis, adult, pool1	10026-101D8	32.00	9.77	4.08	23.84	0.86
testis, adult, pool2	10096-102C6	51.42	9.47	4.51	12.63	2.71
thalamus - adult, donor10196	10168-103B6	57.41	14.35	6.62	0.00	3.31
thalamus, adult, donor10252	10154-103A1	57.04	9.85	6.88	0.16	1.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	55.43	7.70	9.24	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	29.81	4.78	5.27	0.00	1.48
thalamus, newborn, donor10223	10366-105F6	34.52	42.57	9.21	0.00	1.15
throat, adult	10209-103G2	35.45	5.49	3.50	0.00	1.25
throat, fetal, donor1	10061-101H7	28.34	14.02	10.06	0.61	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	11.73	18.88	3.18	1.39	0.00
thymus, adult, pool1	10027-101D9	15.01	68.89	14.81	2.39	0.20
thymus, fetal, pool1	10043-101F7	24.42	96.63	18.81	1.35	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	21.67	9.84	3.32	0.27	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	32.41	8.52	4.19	0.00	0.98
thyroid, adult, pool1	10028-101E1	30.05	2.61	2.89	0.28	1.87
thyroid, fetal, donor1	10060-101H6	23.99	2.90	5.01	0.00	2.64
tongue epidermis (fungiform papillae), donor1	10288-104F9	36.96	3.08	6.16	0.00	0.00
tongue, adult	10203-103F5	29.77	8.61	3.26	0.23	0.23
tongue, fetal, donor1	10059-101H5	21.28	4.73	2.76	0.00	0.79
tonsil, adult, pool1	10047-101G2	33.96	18.63	6.81	0.40	0.70
trachea, adult, pool1	10029-101E2	26.34	7.12	3.44	0.25	0.65
trachea, fetal, donor1	10058-101H4	27.70	8.08	7.69	0.00	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	20.19	5.67	2.48	1.77	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	20.77	6.08	4.76	0.51	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	31.18	22.56	9.40	0.78	0.94
tridermal teratoma cell line:HGRT	10694-109G1	11.42	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	16.93	6.26	4.49	0.17	0.85
umbilical cord, fetal, donor1	10057-101H3	33.38	4.17	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	49.99	12.29	6.48	0.17	3.75
uterus, fetal, donor1	10055-101H1	20.99	11.77	5.63	0.51	1.02
vagina, adult	10204-103F6	19.39	1.29	1.94	0.00	0.00
vein, adult	10191-103E2	18.85	11.62	3.73	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	5.07	5.87	1.87	0.53	0.27